Literature DB >> 12718928

Maximum-likelihood crystallization.

Bernhard Rupp1.   

Abstract

The crystallization facility of the TB Structural Genomics Consortium, one of nine NIH-sponsored structural genomics pilot projects, employs a combinatorial random sampling technique in high-throughput crystallization screening. Although data are still sparse and a comprehensive analysis cannot be performed at this stage, preliminary results appear to validate the random-screening concept. A discussion of statistical crystallization data analysis aims to draw attention to the need for comprehensive and valid sampling protocols. In view of limited overlap in techniques and sampling parameters between the publicly funded high-throughput crystallography initiatives, exchange of information should be encouraged, aiming to effectively integrate data mining efforts into a comprehensive predictive framework for protein crystallization.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12718928     DOI: 10.1016/s1047-8477(03)00047-9

Source DB:  PubMed          Journal:  J Struct Biol        ISSN: 1047-8477            Impact factor:   2.867


  13 in total

1.  Laboratory scale structural genomics.

Authors:  Brent W Segelke; Johana Schafer; Matthew A Coleman; Tim P Lekin; Dominique Toppani; Krzysztof J Skowronek; Katherine A Kantardjieff; Bernhard Rupp
Journal:  J Struct Funct Genomics       Date:  2004

Review 2.  Protein crystallization in the structural genomics era.

Authors:  Alexander McPherson
Journal:  J Struct Funct Genomics       Date:  2004

3.  Production, crystallization and X-ray characterization of chemically glycosylated hen egg-white lysozyme.

Authors:  F J López-Jaramillo; F Pérez-Banderas; F Hernández-Mateo; F Santoyo-González
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2005-04-01

4.  Porous nucleating agents for protein crystallization.

Authors:  Sahir Khurshid; Emmanuel Saridakis; Lata Govada; Naomi E Chayen
Journal:  Nat Protoc       Date:  2014-06-12       Impact factor: 13.491

5.  Shotgun crystallization strategy for structural genomics II: crystallization conditions that produce high resolution structures for T. maritima proteins.

Authors:  Rebecca Page; Ashley M Deacon; Scott A Lesley; Raymond C Stevens
Journal:  J Struct Funct Genomics       Date:  2005

6.  The Scottish Structural Proteomics Facility: targets, methods and outputs.

Authors:  Muse Oke; Lester G Carter; Kenneth A Johnson; Huanting Liu; Stephen A McMahon; Xuan Yan; Melina Kerou; Nadine D Weikart; Nadia Kadi; Md Arif Sheikh; Stefan Schmelz; Mark Dorward; Michal Zawadzki; Christopher Cozens; Helen Falconer; Helen Powers; Ian M Overton; C A Johannes van Niekerk; Xu Peng; Prakash Patel; Roger A Garrett; David Prangishvili; Catherine H Botting; Peter J Coote; David T F Dryden; Geoffrey J Barton; Ulrich Schwarz-Linek; Gregory L Challis; Garry L Taylor; Malcolm F White; James H Naismith
Journal:  J Struct Funct Genomics       Date:  2010-04-24

7.  Promoting crystallization of antibody-antigen complexes via microseed matrix screening.

Authors:  Galina Obmolova; Thomas J Malia; Alexey Teplyakov; Raymond Sweet; Gary L Gilliland
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-07-14

8.  Pi sampling: a methodical and flexible approach to initial macromolecular crystallization screening.

Authors:  Fabrice Gorrec; Colin M Palmer; Guillaume Lebon; Tony Warne
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-04-07

9.  On the need for an international effort to capture, share and use crystallization screening data.

Authors:  Janet Newman; Evan E Bolton; Jochen Müller-Dieckmann; Vincent J Fazio; D Travis Gallagher; David Lovell; Joseph R Luft; Thomas S Peat; David Ratcliffe; Roger A Sayle; Edward H Snell; Kerry Taylor; Pascal Vallotton; Sameer Velanker; Frank von Delft
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-02-15

10.  CorA is a copper repressible surface-associated copper(I)-binding protein produced in Methylomicrobium album BG8.

Authors:  Kenneth A Johnson; Thomas Ve; Oivind Larsen; Rolf B Pedersen; Johan R Lillehaug; Harald B Jensen; Ronny Helland; Odd A Karlsen
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.